9H49
Crystal structure of the adduct between human serum transferrin (apo-form) and cisplatin
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID23-1 |
Synchrotron site | ESRF |
Beamline | ID23-1 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2023-02-04 |
Detector | DECTRIS EIGER2 X CdTe 16M |
Wavelength(s) | 0.8856 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 88.184, 103.680, 200.283 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 80.840 - 3.520 |
R-factor | 0.23152 |
Rwork | 0.231 |
R-free | 0.24936 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.002 |
RMSD bond angle | 0.936 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0419) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 80.840 | 3.580 |
High resolution limit [Å] | 3.520 | 3.520 |
Number of reflections | 23356 | 1147 |
<I/σ(I)> | 7.6 | 0.8 |
Completeness [%] | 100.0 | 100 |
Redundancy | 10.9 | 11.3 |
CC(1/2) | 1.000 | 0.400 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 7 | 293 | 20% w/v PEG 3350 and 200 mM ammonium citrate pH 7.0 |